Farallon Capital Management LLC Acquires Shares of 3,622 Veeva Systems Inc. (NYSE:VEEV)

Farallon Capital Management LLC bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,622 shares of the technology company's stock, valued at approximately $663,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in VEEV. Advisors Asset Management Inc. bought a new stake in Veeva Systems during the 1st quarter worth approximately $28,000. DSM Capital Partners LLC purchased a new stake in Veeva Systems in the 4th quarter valued at $29,000. Vermillion & White Wealth Management Group LLC purchased a new position in Veeva Systems during the 4th quarter worth $32,000. Blue Trust Inc. grew its stake in shares of Veeva Systems by 3,460.0% in the 2nd quarter. Blue Trust Inc. now owns 178 shares of the technology company's stock worth $33,000 after acquiring an additional 173 shares in the last quarter. Finally, First Financial Corp IN purchased a new stake in shares of Veeva Systems in the first quarter valued at about $35,000. Institutional investors and hedge funds own 88.20% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on VEEV. JPMorgan Chase & Co. boosted their price target on shares of Veeva Systems from $203.00 to $208.00 and gave the stock a "neutral" rating in a report on Monday, September 9th. Robert W. Baird upped their target price on Veeva Systems from $245.00 to $251.00 and gave the company an "outperform" rating in a report on Thursday, August 29th. UBS Group lifted their price target on Veeva Systems from $185.00 to $215.00 and gave the stock a "neutral" rating in a report on Monday, August 26th. Morgan Stanley decreased their target price on Veeva Systems from $210.00 to $173.00 and set an "underweight" rating for the company in a research report on Friday, May 31st. Finally, TD Cowen boosted their price target on shares of Veeva Systems from $180.00 to $192.00 and gave the stock a "hold" rating in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $229.96.

Insiders Place Their Bets

In other news, SVP Jonathan Faddis sold 2,353 shares of Veeva Systems stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total transaction of $470,600.00. Following the completion of the sale, the senior vice president now directly owns 9,035 shares of the company's stock, valued at approximately $1,807,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 10.50% of the company's stock.

Veeva Systems Price Performance

VEEV opened at $211.04 on Tuesday. Veeva Systems Inc. has a one year low of $162.72 and a one year high of $236.90. The firm has a market capitalization of $34.12 billion, a P/E ratio of 62.25, a price-to-earnings-growth ratio of 2.12 and a beta of 0.81. The company has a fifty day moving average price of $199.76 and a 200-day moving average price of $201.29.

Veeva Systems (NYSE:VEEV - Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The technology company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.03. Veeva Systems had a return on equity of 13.30% and a net margin of 23.91%. The firm had revenue of $676.18 million for the quarter, compared to analysts' expectations of $667.21 million. On average, analysts expect that Veeva Systems Inc. will post 4.2 earnings per share for the current year.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.